People: HHS Secretary Appoints New Deputy Director At NIH Institute

Marvin Cassman has been appointed deputy director, National Institute of General Medical Sciences, by Health and Human Services Secretary Louis W. Sullivan. Cassman, 53, formerly directed NIGMS' Biophysics and Physiological Sciences Program. NIGMS, a component of the National Institutes of Health, funds research and training in the basic biomedical sciences. Its programs encompass the cellular and molecular basis of disease, genetics, pharmacology, biorelated chemistry, biophysics, physiologic


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Marvin Cassman has been appointed deputy director, National Institute of General Medical Sciences, by Health and Human Services Secretary Louis W. Sullivan. Cassman, 53, formerly directed NIGMS' Biophysics and Physiological Sciences Program.

NIGMS, a component of the National Institutes of Health, funds research and training in the basic biomedical sciences. Its programs encompass the cellular and molecular basis of disease, genetics, pharmacology, biorelated chemistry, biophysics, physiological sciences, and minority biomedical research and training. In his new position, Cassman will assist NIGMS Director Ruth Kirschstein in executing policies, coordinating activities, and allocating resources. He will also represent the institute in NIH forums and in dealings with other agencies, outside scientific organizations, and international scientific groups.

The new deputy director says one of his primary responsibilities will be dealing with policy issues, including budgetary concerns, such as "how to deal with the stress of a constricting funding base." It is "very painful," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours